Haemonetics (HAE) Other Non-Current Assets (2010 - 2026)

Haemonetics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $141.7 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 13.63% year-over-year to $141.7 million; the TTM figure through Mar 2026 stood at $141.7 million (down 13.63% YoY), while the FY2026 annual figure was $141.7 million, down 13.63% from the prior year.
• Other Non-Current Assets was $141.7 million for Q1 2026 at Haemonetics, down from $216.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $216.1 million in Q4 2025 to a low of $63.2 million in Q2 2022.
• Historically, Other Non-Current Assets has averaged $131.8 million across 5 years, with a median of $131.9 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets surged 69.25% in 2023, then dropped 13.63% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $103.3 million in 2022, then grew by 23.39% to $127.4 million in 2023, then advanced by 25.87% to $160.4 million in 2024, then surged by 34.71% to $216.1 million in 2025, then tumbled by 34.41% to $141.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $141.7 million (Q1 2026), $216.1 million (Q4 2025), and $208.0 million (Q3 2025), per Business Quant data.